How many clinical trials are there for Light Chain Nephropathy?

PlainTrial tracks 1 US clinical trials for Light Chain Nephropathy, of which 1 are currently recruiting.

Which interventions appear most often on Light Chain Nephropathy trial records?

Daratumumab is the most-linked intervention name on Light Chain Nephropathy records (1 trial links), followed by Plasma exchange. Names are sponsor-reported on ClinicalTrials.gov.

How do I find a recruiting trial for Light Chain Nephropathy?

Use the trial list filtered by Recruiting status, or visit the trial finder to search by condition and state. Always discuss with your healthcare provider.

Is this data current?

Data is from ClinicalTrials.gov. Trial status may have changed. Always verify at ClinicalTrials.gov before making participation decisions.

Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

Light Chain Nephropathy clinical trials

Compiled by PlainTrial · August 8, 2026

1 of 1 indexed Light Chain Nephropathy trials are currently recruiting.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Light Chain Nephropathy: 1 US clinical trial tracked, 1 recruiting.

Light Chain Nephropathy is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Brigham and Women's Hospital, running 1 of these trials.

Enrollment posture brief

Registry condition light-chain-nephropathy

Volume-matched condition peers

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Open-enrollment share among volume-matched conditions near Light Chain Nephropathy

Light Chain Nephropathy lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Light Chain Nephropathy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

Light Chain Nephropathy is recruiting above its size-band peers.

1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Open and recent trials

1 total, page 1 of 1

RECRUITING 450 participants

Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy

Brigham and Women's Hospital

NCT06483139

Phase Distribution

Phase data not available

Top Sponsors

Brigham and Women's Hospital 1 trials

Named interventions

Most-linked intervention names on Light Chain Nephropathy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Daratumumab Drug

1 trials

Plasma exchange Procedure

1 trials

US sites by state

Facility locations filed on Light Chain Nephropathy trials. A trial with sites in several states counts in each.

Massachusetts 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Light Chain Nephropathy page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

1 Light Chain Nephropathy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
Brigham and Women's Hospital sponsors the most Light Chain Nephropathy trials on record, review their full trial history before evaluating a specific study. See Brigham and Women's Hospital's trials
Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Light Chain Nephropathy condition card totals 1 registered trials; most-linked intervention Daratumumab; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.